| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2022-03-31 | 2021-03-31 | |
| Revenue | 0.00 | 0.00 | |
| Cost of Revenue | 0.78 | 0.00 | |
| Gross Profit | -0.78 | 0.00 | |
| Operating Expenses | 0.00 | 0.09 | |
| Research & Development | 0.00 | 0.00 | |
| Selling, General and Administrative | 0.00 | 0.00 | |
| Other Operating Expenses | 0.00 | 0.09 | |
| Operating Income | -0.78 | -0.09 | |
| Net Non-Operating Interest | 20.2 | 0.00 | |
| Interest Income | 0.00 | 0.00 | |
| Interest Expense | -20.2 | 0.00 | |
| Equity & Other Income/(Expense) | 0.00 | 0.00 | |
| Income Before Tax | 19.4 | -0.09 | |
| Income Tax Expense | -20.2 | 0.00 | |
| Income Attributable to Non-Controlling Interest | 0.00 | 0.00 | |
| Net Income | 39.6 | -0.09 | |
| Depreciation and Amortization | 20.2 | 0.21 | |
| EBITDA | 19.4 | 0.12 | |
| Earnings Per Share (EPS) | 1.580 | -0.003 | |
| Diluted Earnings Per Share | 1.580 | -0.003 | |
| Weighted Average Shares Outstanding | 25.0 | 25.0 | |
| Diluted Weighted Average Shares Outstanding | 25.0 | 25.0 |
